Friday, December 2, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

LOS ANGELES - Questcor Pharmaceuticals propped up its stock price with false and misleading statements and the price fell from $310.13 to $19.08 in a day when the truth came out, shareholders claim in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...